News for ProAssurance Corporation (PRA)

U.S. stocks were mixed, with the Dow Jones gaining over 100 points on Tuesday. Shares of Itron, Inc. ITRI rose sharply during Tuesday's session after the compa...

ProAssurance adopts a defensive strategy amid rising jury verdicts and social inflation, with a 14% stock surge and a $20 price target from analyst Matthew Carletti.

PRA's fourth-quarter earnings benefit from higher investment income and lower expenses, partially offset by lower premiums in the Specialty P&C segment.

ProAssurance Corporation (NYSE:PRA) Q4 2024 Earnings Conference Call February 25, 2025 10:00 AM ETCompany ParticipantsHeather Wietzel - Senior Vice...

While the top- and bottom-line numbers for ProAssurance (PRA) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap val

ProAssurance (PRA) Q4 results: Non-GAAP EPS hits $0.36, surpassing estimates by $0.17. Revenue of $290.1M beats by $15.54M.

Besides Wall Street's top -and-bottom-line estimates for ProAssurance (PRA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.

ProAssurance (PRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The Third Avenue Small-Cap Value Fund (TVSVX) returned -4.38% during Q4 2024. Click here to read the full commentary.

ProAssurance faces challenges in medical malpractice insurance, but shows improvement in net income. See why I rate PRA stock as a Strong Buy.

Sprouts Farmers, ProAssurance, Stride and Calavo Growers have been highlighted in this Screen of The Week article.

PRA's third-quarter earnings benefit from improving underwriting results in its Specialty P&C segment. Declining profits in the Segregated Portfolio Cell Reinsurance unit partially offset the positives.

ProAssurance Corporation (NYSE:PRA) Q3 2024 Earnings Conference Call November 8, 2024 10:00 AM ETCompany ParticipantsHeather Wietzel – Senior Vice...

Although the revenue and EPS for ProAssurance (PRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

ProAssurance to Announce Third Quarter 2024 Results on Thursday, November 7, 2024

AMERISAFE, Inc. (NASDAQ: AMSF) is currently considered expensive on a relative basis, with the stock trading at a 22X forward 12-month price-to-earnings (P/E) ratio, which is at a premium compared with its five-year median of 20.21X and the Zacks Insurance - Accident and Health average of 13.36X.

Appealing valuation, upward trend in earnings estimates and rising investment income bode well for PRA.

The Progressive, JD.com, Mission Produce and ProAssurance have been highlighted in this Screen of The Week article.